Skip to main content

Table 2 Clinical characteristics

From: Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience

Characteristic

N (%)

Diagnosis of diabetes

Yes

5 (29.4)

No

12 (70.6)

Ever taken volanesorsen

Currently taking

6 (35.3)

Previously taken

7 (41.2)

Never

4 (23.5)

Time on volanesorsen

Median (IQR)

Time since starting treatment with volanesorsen (years)1 (N = 6)

2.58 (1.77–3.15)

Time on volanesorsen before stopping (years) (N = 7)

0.83 (0.46–1.58)

Episodes of acute pancreatitis

Time since last AP episode (years) (N = 15)2

2.00 (0.58–6.33)

Number of episodes in the last 5 years (N = 15)2

2.00 (0–4.5)

Number of episodes since on volanesorsen (N = 6)

0.0 (0–0.75)

  1. 1Those currently on volanesorsen.
  2. 2Response of two participants were missing. IQR Interquartile range. Data are shown as median (IQR) or N (%)